ZOMETA zoledronic acid 4 mg/100 mL injection solution vial אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

zometa zoledronic acid 4 mg/100 ml injection solution vial

scigen australia pty ltd - zoledronic acid, quantity: 4 mg (equivalent: zoledronic acid monohydrate, qty 4.264 mg) - injection, solution - excipient ingredients: water for injections; mannitol; nitrogen; sodium citrate dihydrate - prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone. treatment of tumour-induced hypercalcaemia.

DBL ZOLENDRONIC ACID CONCENTRATED INJECTION 4 mg/5 mL concentrated injection vial אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

dbl zolendronic acid concentrated injection 4 mg/5 ml concentrated injection vial

pfizer australia pty ltd - zoledronic acid monohydrate, quantity: 4.3 mg (equivalent: zoledronic acid, qty 4 mg) - injection, concentrated - excipient ingredients: water for injections; mannitol; sodium citrate dihydrate - ? prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone.,? treatment of tumour-induced hypercalcaemia

Alka-Seltzer Effervescent Tablets;Acetylsalicylic acid (Aspirin);Sodium Hyd Carbonate;Citric acid מלטה - אנגלית - Medicines Authority

alka-seltzer effervescent tablets;acetylsalicylic acid (aspirin);sodium hyd carbonate;citric acid

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - citric acid, acetylsalicylic acid, sodium hydrogen, carbonate - effervescent tablet - acetylsalicylic acid 324 mg citric acid 965 mg sodium hydrogen carbonate 1744 mg - analgesics

CARTIA ישראל - אנגלית - Ministry of Health

cartia

padagis israel agencies ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

MICROPIRIN 75 ישראל - אנגלית - Ministry of Health

micropirin 75

dexcel ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 75 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

MICROPIRIN 100 ישראל - אנגלית - Ministry of Health

micropirin 100

dexcel ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

TEVAPIRIN ישראל - אנגלית - Ministry of Health

tevapirin

teva pharmaceutical industries ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

TEVAPIRIN ישראל - אנגלית - Ministry of Health

tevapirin

teva pharmaceutical industries ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

CARDIOPIRIN ישראל - אנגלית - Ministry of Health

cardiopirin

dexcel ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.